14 employees
MODAG aims to provide a novel approach for treating neurodegenerative diseases by combining targeted small molecule therapeutics.
2013
$14M
from 1 investors over 1 rounds
MODAG raised $14M on June 27, 2019
Investors: Massa Investment Group